Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:MASS NASDAQ:NAUT NASDAQ:PRE NASDAQ:RPID On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeMASS908 Devices$7.28$6.85$4.61▼$9.34$275.29M0.57269,101 shs182,256 shsNAUTNautilus Biotechnology$2.54$2.94$0.62▼$4.31$322.78M0.75378,196 shs362,595 shsPREPrenetics Global$16.77$18.41$5.58▼$23.63$282.98M0.15233,247 shs192,163 shsRPIDRapid Micro Biosystems$2.05$2.33$1.90▼$4.94$93.20M1.52152,832 shs65,947 shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceMASS908 Devices0.00%+9.64%+8.01%+7.22%+51.67%NAUTNautilus Biotechnology0.00%+7.63%-3.05%-10.56%+246.95%PREPrenetics Global0.00%+15.34%-8.51%+5.47%+62.66%RPIDRapid Micro Biosystems0.00%+4.59%-10.09%-50.36%-37.31%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeMASS908 Devices$7.28$6.85$4.61▼$9.34$275.29M0.57269,101 shs182,256 shsNAUTNautilus Biotechnology$2.54$2.94$0.62▼$4.31$322.78M0.75378,196 shs362,595 shsPREPrenetics Global$16.77$18.41$5.58▼$23.63$282.98M0.15233,247 shs192,163 shsRPIDRapid Micro Biosystems$2.05$2.33$1.90▼$4.94$93.20M1.52152,832 shs65,947 shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceMASS908 Devices0.00%+9.64%+8.01%+7.22%+51.67%NAUTNautilus Biotechnology0.00%+7.63%-3.05%-10.56%+246.95%PREPrenetics Global0.00%+15.34%-8.51%+5.47%+62.66%RPIDRapid Micro Biosystems0.00%+4.59%-10.09%-50.36%-37.31%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceMASS908 Devices 2.00Hold$12.0064.84% UpsideNAUTNautilus Biotechnology 2.00Hold$4.0057.48% UpsidePREPrenetics Global 2.50Moderate Buy$32.3392.80% UpsideRPIDRapid Micro Biosystems 2.00Hold$7.00241.46% UpsideCurrent Analyst Ratings BreakdownLatest RPID, NAUT, MASS, and PRE Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/22/2026RPIDRapid Micro Biosystems Lake Street CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$8.00 ➝ $7.005/11/2026MASS908 Devices Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold (C-) ➝ Sell (D-)4/21/2026NAUTNautilus Biotechnology Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)4/21/2026PREPrenetics Global Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)4/21/2026RPIDRapid Micro Biosystems Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)4/13/2026MASS908 Devices Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (D+) ➝ Hold (C-)3/16/2026PREPrenetics Global Lake Street CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$29.002/27/2026NAUTNautilus Biotechnology GuggenheimSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$2.50 ➝ $4.00(Data available from 5/26/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookMASS908 Devices$56.20M4.90N/AN/A$3.55 per share2.05NAUTNautilus BiotechnologyN/AN/AN/AN/A$1.14 per shareN/APREPrenetics Global$92.39M3.06N/AN/A$9.27 per share1.81RPIDRapid Micro Biosystems$33.59M2.77N/AN/A$0.45 per share4.56Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateMASS908 Devices$19.49M-$1.00N/AN/AN/A-62.40%-14.03%-10.40%8/4/2026 (Estimated)NAUTNautilus Biotechnology-$59M-$0.46N/AN/AN/AN/A-35.04%-29.16%8/4/2026 (Estimated)PREPrenetics Global-$37.71M-$4.02N/AN/AN/A-61.33%-19.61%-15.33%N/ARPIDRapid Micro Biosystems-$47.12M-$1.12N/AN/AN/A-145.81%-131.52%-67.48%7/31/2026 (Estimated)Latest RPID, NAUT, MASS, and PRE EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/13/2026Q1 2026RPIDRapid Micro Biosystems-$0.25-$0.31-$0.06-$0.31$7.60 million$8.00 million4/28/2026Q1 2026NAUTNautilus Biotechnology-$0.1450-$0.12+$0.0250-$0.12$0.25 millionN/A3/12/2026Q4 2025RPIDRapid Micro Biosystems-$0.23-$0.28-$0.05-$0.28$10.93 million$11.28 million3/3/2026Q4 2025MASS908 Devices-$0.06-$0.05+$0.01$0.10$16.19 million$17.38 million2/26/2026Q4 2025NAUTNautilus Biotechnology-$0.14-$0.11+$0.03-$0.11N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthMASS908 DevicesN/AN/AN/AN/AN/ANAUTNautilus BiotechnologyN/AN/AN/AN/AN/APREPrenetics GlobalN/AN/AN/AN/AN/ARPIDRapid Micro BiosystemsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioMASS908 DevicesN/A3.583.25NAUTNautilus BiotechnologyN/A11.8511.85PREPrenetics GlobalN/A2.972.72RPIDRapid Micro Biosystems0.932.572.36Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipMASS908 Devices88.06%NAUTNautilus Biotechnology50.71%PREPrenetics Global25.01%RPIDRapid Micro Biosystems52.60%Insider OwnershipCompanyInsider OwnershipMASS908 Devices28.20%NAUTNautilus Biotechnology41.10%PREPrenetics Global7.80%RPIDRapid Micro Biosystems12.70%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableMASS908 Devices6037.81 million27.15 millionOptionableNAUTNautilus Biotechnology130127.08 million74.85 millionOptionablePREPrenetics Global116.87 million15.56 millionNot OptionableRPIDRapid Micro Biosystems20045.46 million39.69 millionNot OptionableRPID, NAUT, MASS, and PRE HeadlinesRecent News About These CompaniesRapid Micro Biosystems prices $9.8M capital raise with up to $21.7M in additional warrant potentialMay 19, 2026 | msn.comFinancial Contrast: Rapid Micro Biosystems (NASDAQ:RPID) versus DarioHealth (NASDAQ:DRIO)May 19, 2026 | americanbankingnews.comRapid Micro Biosystems Announces Pricing of $9.8 Million Underwritten Public Offering of Class A Common Stock and WarrantsMay 18, 2026 | quiverquant.comQRapid Micro Biosystems Announces Pricing of Up to Approximately $32 Million Underwritten OfferingMay 18, 2026 | globenewswire.comRapid Micro Biosystems Earnings Call Balances Growth And RiskMay 16, 2026 | theglobeandmail.comRapid Micro Biosystems Q1 2026 Earnings Call: Complete TranscriptMay 14, 2026 | finance.yahoo.comRapid Micro Biosystems Inc (RPID) Q1 2026 Earnings Call Highlights: Strong Revenue Growth ...May 14, 2026 | finance.yahoo.comRapid Micro Biosystems Q1 Earnings Call HighlightsMay 13, 2026 | marketbeat.comRapid Micro Biosystems, Inc. (RPID) Q1 2026 Earnings Call TranscriptMay 13, 2026 | seekingalpha.comRapid Micro Biosystems, Inc. (RPID) Reports Q1 Loss, Tops Revenue EstimatesMay 13, 2026 | zacks.comRapid Micro Biosystems Reports First Quarter 2026 Revenue of $8.0 Million with 11% Year-Over-Year GrowthMay 13, 2026 | quiverquant.comQRapid Micro Biosystems Reports First Quarter 2026 Financial ResultsMay 13, 2026 | globenewswire.comRapid Micro Biosystems (NASDAQ:RPID) Stock Rating Lowered by Wall Street ZenMay 9, 2026 | marketbeat.comRapid Micro Biosystems to Announce First Quarter 2026 Financial Results on May 13, 2026May 6, 2026 | globenewswire.comRapid Micro Biosystems (RPID) Projected to Post Quarterly Earnings on FridayMay 1, 2026 | marketbeat.comRapid Micro Biosystems, Inc. (NASDAQ:RPID) Short Interest Up 44.1% in AprilApril 28, 2026 | marketbeat.comWhite Brook Capital Shared Insights on Rapid Micro Biosystems (RPID)April 23, 2026 | insidermonkey.comWhat Makes Rapid Micro Biosystems (RPID) a New Buy StockApril 14, 2026 | zacks.comRapid Micro Biosystems Faces ESG-Related Reputational and Operational Risks Amid Evolving Sustainability RulesMarch 14, 2026 | tipranks.comInsider Selling: Rapid Micro Biosystems (NASDAQ:RPID) CFO Sells 7,480 Shares of StockMarch 13, 2026 | insidertrades.comRapid Micro Biosystems Inc (RPID) Q4 2025 Earnings Report Preview: What To Look ForMarch 13, 2026 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesThe $880M Bet to Survive Real Estate's ResetBy Jeffrey Neal Johnson | April 28, 2026Is Oracle Undervalued as Cloud Growth Accelerates?By Thomas Hughes | April 29, 2026Lilly's Double-Beat Widens the GLP-1 Gap—And a New Pill Could Make It PermanentBy Nathan Reiff | May 1, 2026AI Dividend Increases: 3 Massive Winners Boosting PayoutsBy Leo Miller | May 11, 2026Oklo Stock Could Be Ready for Another Massive RunBy Thomas Hughes | May 14, 2026RPID, NAUT, MASS, and PRE Company Descriptions908 Devices NASDAQ:MASS$7.28 0.00 (0.00%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$7.26 -0.02 (-0.21%) As of 05/22/2026 06:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling. Its products also comprise Maven and Trace C2, an online device for bioprocess monitoring and control; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. The company operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of the Americas. 908 Devices Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.Nautilus Biotechnology NASDAQ:NAUT$2.54 0.00 (0.00%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$2.52 -0.02 (-0.91%) As of 05/22/2026 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. The company develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. It also offers proteome analysis system, a high-resolution optical imaging system for integrated fluidics and liquid handling sub-system. In addition, the company provides sample preparation, flow cells, multi-affinity probe reagents, and instrument buffers system to perform multi-cycle analysis runs. Nautilus Biotechnology, Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.Prenetics Global NASDAQ:PRE$16.77 0.00 (0.00%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$17.19 +0.42 (+2.50%) As of 05/22/2026 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Prenetics Global Limited, a genomics-driven health sciences company, engages in revolutionizing prevention, early detection, and treatment. It offers CircleDNA, a prevention arm that uses whole exome sequencing to offer comprehensive consumer DNA test. The company also, through its joint venture, Insighta, engages in pioneering multi-cancer early detection technologies. In addition, the company, through its equity interests in ACT Genomics Holdings Company Limited, is involved in genomic profiling of solid tumors through ACTOnco. Prenetics Global Limited was founded in 2007 and is based in Quarry Bay, Hong Kong.Rapid Micro Biosystems NASDAQ:RPID$2.05 0.00 (0.00%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$2.06 +0.01 (+0.24%) As of 05/22/2026 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides onsite technical training services. Its solutions are used in environmental monitoring, water, bioburden, and sterility release testing applications. In addition, the company offers RMBNucleus software for the Growth Direct system; RMBNucleus Mold Alarm signals at the first sign of mold detection; RMBNucleus Central Manager portal streamlines coordination of multiple instruments; and Growth Direct LIMS connection software. Rapid Micro Biosystems, Inc. was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007. The company was incorporated in 2006 and is headquartered in Lowell, Massachusetts. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 05/18 - 05/22 Ross Stores Earnings Beat Sends Stock To New Highs Was Decker’s Double Beat a Bullish Signal—Or Mere HOKA’s-Pocus? Workday Validates AI Flywheel: Stock Price Recovery Begins Apparel Earnings Winners and Losers: Ralph Lauren Takes Off SpaceX IPO: Opportunity? Or the Ultimate Hype Trade? The Careful Consumer: What Q1 Earnings Reveal—And Where Cracks May Appear Overextended, e.l.f. Beauty Is Primed to Rebound in Back Half Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
